Consolidated Statement of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ 523,368	$ 782,916
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	138,037	131,388
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions	807	(164,930)
Provision for current expected credit losses	5,009	2,961
Deferred taxes	(68,627)	(1,733)
Other, net	5,627	1,597
Changes in operating assets and liabilities, net of acquisitions:
Receivables	(749,650)	(779,455)
Inventories	(1,036,401)	(1,417,233)
Accounts payable and accrued expenses	1,232,312	1,441,469
Other liabilities	(198,067)	(177,172)
Net cash provided by (used in) operating activities	(147,585)	(180,192)
Cash flows from investing activities:
Acquisition of property, plant and equipment	(142,449)	(122,598)
Proceeds from disposition of property, plant and equipment	2,330	5,034
Expenditures for major repairs	(8,274)	(27,398)
Changes in CHS Capital notes receivable, net	83,580	32,098
Financing extended to customers	(50,229)	(39,814)
Payments from customer financing	39,697	42,121
Other investing activities, net	(24,271)	(156)
Net cash provided by (used in) investing activities	(99,616)	(110,713)
Cash flows from financing activities:
Proceeds from lines of credit and long-term borrowings	975,374	2,054,507
Payments on lines of credit, long-term borrowings and capital lease obligations	(1,106,904)	(1,887,483)
Preferred stock dividends paid	(42,167)	(42,167)
Redemptions of equities	(11,236)	(12,941)
Other financing activities, net	10,429	18,044
Net cash provided by (used in) financing activities	(174,504)	129,960
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(3,969)	1,415
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(425,674)	(159,530)
Cash and cash equivalents and restricted cash at beginning of period	1,844,587	903,474
Cash and cash equivalents and restricted cash at end of period	$ 1,418,913	$ 743,944